Lipid nanoparticle delivery of siRNA targeting Cyp2e1 gene attenuates subacute alcoholic liver injury in mice

OBJECTIVES: To investigate the effect and mechanism of lipid nanoparticle (LNP) delivery of small interfering RNA (siRNA) targeting Cyp2e1 gene on subacute alcoholic liver injury in mice.

METHODS: siRNA targeting Cyp2e1 gene was encapsulated in LNP (si-Cyp2e1 LNP) by microfluidic technique and the resulting LNPs were characterized. The optimal dose of si-Cyp2e1 LNP administration was screened. Forty female C57BL/6N mice were randomly divided into blank control group, model control group, si-Cyp2e1 LNP group, LNP control group and metadoxine group. The subacute alcoholic liver injury mouse model was induced by ethanol feeding for 10 d plus ethanol gavage for the last 3 d. Serum alanine aminotransferase (ALT) and aspartate aminotransferase (AST) activities, and the superoxide dismutase (SOD) activity as well as malondialdehyde, reactive oxygen species, glutathione, triacylglycerol, total cholesterol contents in liver tissue were measured in each group, and liver index was calculated. The expression of genes related to oxidative stress, lipid synthesis and inflammation in each group of mice were measured by realtime RT-PCR.

RESULTS: Compared with the model control group, the levels of liver index, serum ALT, AST activities, malondialdehyde, reactive oxygen species, triacylglycerol, total cholesterol contents in liver tissue decreased, but the SOD activity as well as glutathione increased in the si-Cyp2e1 LNP group (all P<0.01). Hematoxylin-eosin staining result showed disorganized hepatocytes with sparse cytoplasm and a large number of fat vacuoles and necrosis in the model control group, while the si-Cyp2e1 LNP group had uniformly sized and arranged hepatocytes with normal liver tissue morphology and structure. Oil red O staining result showed si-Cyp2e1 LNP group had lower fat content of the liver compared to the model control group (P<0.01), and no fat droplets accumulated. Anti-F4/80 monoclonal antibody fluorescence immunohistochemistry showed that the si-Cyp2e1 LNP group had lower cumulative optical density values compared to the model control group (P<0.01) and no significant inflammatory reaction. Compared with the model control group, the expression of catalytic genes P47phox, P67phox and Gp91phox were reduced (all P<0.01), while the expression of the antioxidant enzyme genes Sod1, Gsh-rd and Gsh-px were increased (all P<0.01). The mRNA expression of the lipid metabolism genes Pgc-1α and Cpt1 were increased (all P<0.01) and the lipid synthesis-related genes Srebp1c, Acc and Fasn were decreased (all P<0.01); the expression of liver inflammation-related genes Tgf-β, Tnf-α and Il-6 were decreased (all P<0.01).

CONCLUSIONS: The si-Cyp2e1 LNP may attenuate subacute alcoholic liver injury in mice mainly by reducing reactive oxygen levels, increasing antioxidant activity, blocking oxidative stress pathways and reducing ethanol-induced steatosis and inflammation.

Medienart:

E-Artikel

Erscheinungsjahr:

2023

Erschienen:

2023

Enthalten in:

Zur Gesamtaufnahme - volume:52

Enthalten in:

Zhejiang da xue xue bao. Yi xue ban = Journal of Zhejiang University. Medical sciences - 52(2023), 3 vom: 25. Juni, Seite 306-317

Sprache:

Englisch

Weiterer Titel:

脂质纳米粒递送靶向Cyp2e1基因的小干扰RNA可减轻小鼠亚急性酒精性肝损伤

Beteiligte Personen:

Wu, Shuang [VerfasserIn]
Chen, Qiubing [VerfasserIn]
Wang, Yalan [VerfasserIn]
Yin, Hao [VerfasserIn]
Wei, Yuan [VerfasserIn]

Links:

Volltext

Themen:

3K9958V90M
4Y8F71G49Q
97C5T2UQ7J
Antioxidants
Cholesterol
Cytochrome P-450 CYP2E1
EC 1.14.13.-
EC 1.15.1.1
Ethanol
GAN16C9B8O
Glutathione
Inflammation
Journal Article
Lipid Nanoparticles
Lipid metabolic synthesis
Lipid nanoparticles
Lipids
Malondialdehyde
Mice
Oxidative stress
RNA, Small Interfering
Reactive Oxygen Species
Small interfering RNA
Subacute alcoholic liver injury
Superoxide Dismutase
Triglycerides

Anmerkungen:

Date Completed 11.08.2023

Date Revised 28.11.2023

published: Print

Citation Status MEDLINE

doi:

10.3724/zdxbyxb-2022-0729

funding:

Förderinstitution / Projekttitel:

PPN (Katalog-ID):

NLM359773532